Cargando…

The paradox of the first cycle of chemotherapy—transient improvement of contractility and diastolic function after the first cycle of anthracycline-based chemotherapy: a prospective clinical trial

AIMS: Breast cancer is the most common cancer among women, and anthracyclines are the most commonly administered drugs for these patients. Cardiotoxicity is one of the complications, which limits the success of this therapy. Very few studies have evaluated anthracycline toxicities within the first f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stachowiak, Paweł, Wojtarowicz, Andrzej, Milchert-Leszczyńska, Marta, Safranow, Krzysztof, Falco, Michał, Kaliszczak, Robert, Kornacewicz-Jach, Zdzisława
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707113/ https://www.ncbi.nlm.nih.gov/pubmed/29221219 http://dx.doi.org/10.18632/oncotarget.21279

Ejemplares similares

Prognostic role of troponin and natriuretic peptides as biomarkers for deterioration of left ventricular ejection fraction after chemotherapy
por: Stachowiak, Paweł, et al.
Publicado: (2013)

Percutaneous closure of paravalvular leak in the treatment of anemia of mixed etiology in a patient with diabetic complications and chronic inflammation
por: Pelczarska, Magdalena, et al.
Publicado: (2016)

Effect of Eplerenone on Diastolic Function in Women Receiving Anthracycline-Based Chemotherapy for Breast Cancer
por: Davis, Margot K., et al.
Publicado: (2019)

Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017)

Advances in anthracycline chemotherapy : epirubicin /
Publicado: (1984)

Prognostic Value of Chemotherapy-Induced Neutropenia at the First Cycle in Invasive Breast Cancer
por: Ma, Rui-Min, et al.
Publicado: (2016)

Validation of the FENCE Risk Groups for Prediction of Febrile Neutropenia With First-Cycle Chemotherapy
por: Zatarah, Razan, et al.
Publicado: (2022)

Maintenance chemotherapy after 6 cycles of platinum-doublet regimen in anthracycline-and taxane-pretreated metastatic breast cancer
por: Joung, Eun Kyo, et al.
Publicado: (2021)

Novel Evidence of the Increase in Angiogenic Factor Plasma Levels after Lineage-Negative Stem/Progenitor Cell Intracoronary Infusion in Patients with Acute Myocardial Infarction
por: Baumert, Bartłomiej, et al.
Publicado: (2019)

The Effect of Intracoronary Infusion of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells on Remodeling of Post-Infarcted Heart in Patient with Acute Myocardial Infarction
por: Peregud-Pogorzelska, Małgorzata, et al.
Publicado: (2020)

Risk assessment model for first-cycle chemotherapy-induced neutropenia in patients with solid tumours
por: LÓPEZ-POUSA, A, et al.
Publicado: (2010)

The Most Common Side Effects Experienced by Patients Were Receiving First Cycle of Chemotherapy
por: ALTUN, İnsaf, et al.
Publicado: (2018)

Dynamic trajectory of platelet counts after the first cycle of induction chemotherapy in AML patients
por: Bi, Yazhen, et al.
Publicado: (2022)

AMPD1 gene mutations are associated with obesity and diabetes in Polish patients with cardiovascular diseases
por: Safranow, Krzysztof, et al.
Publicado: (2010)

Surrogate markers and survival in women receiving first-line combination anthracycline chemotherapy for advanced breast cancer
por: Hackshaw, A, et al.
Publicado: (2005)

The effects on anxiety and quality of life of breast cancer patients following completion of the first cycle of chemotherapy
por: Charalambous, Andreas, et al.
Publicado: (2017)

Correction: Dynamic trajectory of platelet counts after the first cycle of induction chemotherapy in AML patients
por: Bi, Yazhen, et al.
Publicado: (2022)

Evaluation of biomarkers for cardiotoxicity of anthracyclin-based chemotherapy
por: Broeyer, F. J. F., et al.
Publicado: (2008)

Cardiotoxicity of Non-Anthracycline Cancer Chemotherapy Agents
por: Briasoulis, Alexandros, et al.
Publicado: (2022)

The Influence of Cell Cycle Regulation on Chemotherapy
por: Sun, Ying, et al.
Publicado: (2021)

Importance of eliminating potential dental focal infection before the first cycle of chemotherapy in patients with hematologic malignancy
por: Shimada, Yasuyuki, et al.
Publicado: (2017)

Phase IIIb Safety and Efficacy of Intravenous NEPA for Prevention of Chemotherapy‐Induced Nausea and Vomiting (CINV) in Patients with Breast Cancer Receiving Initial and Repeat Cycles of Anthracycline and Cyclophosphamide (AC) Chemotherapy
por: Schwartzberg, Lee, et al.
Publicado: (2019)

Systemic autophagy in the therapeutic response to anthracycline-based chemotherapy
por: Castoldi, Francesca, et al.
Publicado: (2018)

RBL2 Regulates Cardiac Sensitivity to Anthracycline Chemotherapy
por: Xia, Peng, et al.
Publicado: (2023)

Clinical Significance of CA125 Level after the First Cycle of Chemotherapy on Survival of Patients with Advanced Ovarian Cancer
por: Lee, Maria, et al.
Publicado: (2016)

Absolute Neutrophil Count after the First Chemotherapy Cycle as a Surrogate Marker for Treatment Outcomes in Patients with Neuroblastoma
por: Lee, Ji Won, et al.
Publicado: (2022)

First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update
por: Reck, M., et al.
Publicado: (2021)

Left Ventricular Diastolic Function Following Anthracycline-Based Chemotherapy in Patients with Breast Cancer without Previous Cardiac Disease—A Meta-Analysis
por: Mincu, Raluca I., et al.
Publicado: (2021)

Factors Affecting Exercise Test Performance in Patients After Liver Transplantation
por: Kotarska, Katarzyna, et al.
Publicado: (2016)

An Indirect Comparison Between Nivolumab + Ipilimumab + Two Cycles of Chemotherapy vs. Pembrolizumab + Chemotherapy as First-Line Treatment for Metastatic Non-Small Cell Lung Cancer
por: Jiang, Panpan, et al.
Publicado: (2021)

Cardiotoxicity by Anthracycline Regimen Chemotherapy Prolonged T Peak to T End Interval
por: Iqbal, Mohammad, et al.
Publicado: (2020)

Fatal Interstitial Pneumonitis Rapidly Developed after the First Cycle of CHOP with Etoposide Combination Chemotherapy in a Patient with Lymphoma
por: Park, Hyung Chul, et al.
Publicado: (2013)

Prognostic nomograms for gastric carcinoma after surgery to assist decision-making for postoperative treatment with chemotherapy cycles <9 or chemotherapy cycles ≥9
por: Li, Yifan, et al.
Publicado: (2022)

The proliferation rate paradox in antimitotic chemotherapy
por: Mitchison, Timothy J.
Publicado: (2012)

Incidence of Chemotherapy-Induced Amenorrhea After Adjuvant Chemotherapy With Taxane and Anthracyclines in Young Patients With Breast Cancer
por: Pourali, Leila, et al.
Publicado: (2013)

Higher neutrophil-to-lymphocyte ratio after the first cycle of the first-line chemotherapy is associated with poor cancer specific survival of upper urinary tract carcinoma patients
por: Hashimoto, Mamoru, et al.
Publicado: (2021)

One Cycle of Concurrent Chemotherapy vs. Two Cycles of Concurrent Chemotherapy With Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer
por: Yu, Hao, et al.
Publicado: (2022)

Survival of soft tissue sarcoma patients after completing six cycles of first-line anthracycline containing treatment: an EORTC-STBSG database study
por: Verschoor, Arie Jan, et al.
Publicado: (2020)

Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse‐preventive immunotherapy in acute myeloid leukaemia
por: Nilsson, Malin S., et al.
Publicado: (2019)

Refining Tumor Treatment in Sinonasal Cancer Using Delta Radiomics of Multi-Parametric MRI after the First Cycle of Induction Chemotherapy
por: Corino, Valentina D. A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_guakfdarc3ggqsnf11eq5f0je8